-transparent.png){kind=logo}
The strains suitable for the development of herpesvirus vaccine were selected as a result of studies on numerous herpes virus strains isolated from patients with relapsing herpes infection of various localizations. Infectious tissue culture antigens were obtained by roller cultivation of chick embryo fibroblast cultures infected with herpesvirus in the presence of 0.2% human serum albumin. A high immunogenic and antigenic activity of the experimental vaccines prepared from these antigens was established. Animal experiments demonstrated the possibility of control of the specific activity of herpesvirus vaccines.
Related Publications
A K Shubladze, and
A N Fomina, and
D S Levina, and
A A Davydova
September 1972,
The Medical clinics of North America,
A K Shubladze, and
A N Fomina, and
D S Levina, and
A A Davydova
January 1996,
Voprosy virusologii,
A K Shubladze, and
A N Fomina, and
D S Levina, and
A A Davydova
January 1973,
Voprosy virusologii,
A K Shubladze, and
A N Fomina, and
D S Levina, and
A A Davydova
January 2016,
Methods in molecular biology (Clifton, N.J.),
A K Shubladze, and
A N Fomina, and
D S Levina, and
A A Davydova
March 1975,
Infection and immunity,
A K Shubladze, and
A N Fomina, and
D S Levina, and
A A Davydova
January 1980,
Journal of biological standardization,
A K Shubladze, and
A N Fomina, and
D S Levina, and
A A Davydova
January 1998,
Vaccine,
A K Shubladze, and
A N Fomina, and
D S Levina, and
A A Davydova
January 2022,
Methods in molecular biology (Clifton, N.J.),
A K Shubladze, and
A N Fomina, and
D S Levina, and
A A Davydova
September 2022,
NPJ vaccines,
A K Shubladze, and
A N Fomina, and
D S Levina, and
A A Davydova
June 2000,
Memory & cognition,
